American Society of Hematology

SHERPA: Blue

People

  1. Zelenetz
    Zelenetz
  2. O'Reilly
    O'Reilly
  3. Kernan
    Kernan
  4. Van Den Brink
    Van Den Brink
  5. Moore
    Moore
  6. Scheinberg
    Scheinberg
  7. Fleisher
    Fleisher
  8. Young
    Young
  9. Hassoun
    Hassoun
  10. Heller
    Heller

Groups

  1. Department of Medicine (70)
  2. Hematologic Malignancies, Division of (64)
  3. Center for Hematologic Malignancies (60)
  4. Sloan Kettering Institute Faculty (39)
  5. GSK Faculty (28)
  6. Pediatrics, Department of (20)
  7. Tow Center for Developmental Oncology (TCDO) (19)
  8. Adult Leukemia (17)
  9. Immunology Program Faculty (17)
  10. Lymphoma (15)
Search Within
  1. "2005"
Formats
  1. Meeting Abstract (78)
  2. Journal Article (34)
Groups
  1. Department of Medicine (70)
  2. Hematologic Malignancies, Division of (64)
  3. Center for Hematologic Malignancies (60)
  4. Sloan Kettering Institute Faculty (39)
  5. GSK Faculty (28)
  6. Pediatrics, Department of (20)

More Groups

People
  1. Stephen Nimer (13)
  2. Andrew Zelenetz (11)
  3. Richard O'Reilly (10)
  4. Julie Feldstein (9)
  5. Marcel Van Den Brink (9)
  6. Nancy Kernan (9)

More People

Years
  1. 2005 (112)
Publications
  1. Blood (112)

Results (112)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Genetic correction of sickle cell disease by co-regulated gamma-globin transgene expression and beta S interference
    Meeting Abstract

    Samakoglu, S.; Usachenko, Y.; Budak-Alpdogan, T.; Acuto, S.; DiMarzo, R.; Maggio, A.; Tisdale, J.; Riviere, I.; Sadelain, M.
    Blood (2005)

    Fulltext@MSK | Save
  • Age significantly influences presentation and patterns of care in patients with newly diagnosed diffuse large cell lymphoma (DLCL): Collective data from 5 centers participating in the National Comprehensive Center Network (NCCN) NHL Outcomes Project
    Meeting Abstract

    Rodriguez, M. A.; Czuczman, M. S.; Friedberg, J. W.; Kho, M. E.; LaCasce, A. S.; Millenson, M.; Auayporn, N.; Niland, J.; ter Veer, A.; Zelenetz, A. D.; more...
    Blood (2005)

    Fulltext@MSK | Save
  • Defibrotide (DF) for the treatment of veno-occlusive disease (VOD) and multi-system organ failure (MOF) post SCT: Analysis of response and survival according to degree and type of MOV
    Meeting Abstract

    Richardson, P. G.; Soiffer, R. J.; Antin, J. H.; Jin, Z.; Kurtzberg, J.; Martin, P. L.; Hockenbery, D.; Murray, K. F.; Vogelsang, G. B.; Chen, A.; more...
    Blood (2005)

    Fulltext@MSK | Save
  • A multicenter phase II trial of bortezomib in patients with previously untreated multiple myeloma: Efficacy with manageable toxicity in patients with unexpectedly high rates of baseline peripheral neuropathy
    Meeting Abstract

    Richardson, P.; Chanan-Khan, A.; Schlossman, R.; Munshi, N.; Wen, P.; Briemberg, H.; Kuter, D.; Oaklander, A.; Lodial, S.; Hassoun, H.; more...
    Blood (2005)

    Fulltext@MSK | Save
  • Allogeneic or autologous stem cell transplantation (SCT) for the treatment of pediatric patients with non-Hodgkins lymphoma (NHL)
    Meeting Abstract

    Ricafort, R.; Trippett, T.; Kernan, N. A.; Small, T. N.; Prockop, S.; Scaradavou, A.; Keating, A.; O'Reilly, R. J.; Boulad, F.
    Blood (2005)

    Fulltext@MSK | Save
  • Graft-versus-tumor activity against renal cell carcinoma in a mouse model of HSCT
    Meeting Abstract

    Ramirez-Montagut, T.; Chow, A.; Kochman, A. A.; Hubbard, V. M.; Suh, D.; Smith, O. M.; Sindhi, H.; Terwey, T. H.; Kim, T. D.; Waldman, E.; more...
    Blood (2005)

    Fulltext@MSK | Save
  • Absolute lymphocyte count recovery predicts superior survival and is independent of the international prognostic index in patients treated with CHOP or R-CHOP chemotherapy for diffuse large B cell lymphoma
    Meeting Abstract

    Porrata, L. F.; Ristow, K. M.; Geyer, S. M.; Markovic, S. N.; Persky, D. O.; Colgan, J. P.; White, W. L.; Witzig, T. E.; Inwards, D. J.; Ansell, S. M.; more...
    Blood (2005)

    Fulltext@MSK | Save
  • Depletion of NUP98: A common leukemogenetic mechanism in AML?
    Meeting Abstract

    Plasilova, M.; Chung, K.; Shieh, J.H.; Fields, R. J.; Morrone, G.; Chadburn, A.; Knowles, D. M.; Zhou, P. B.; Moore, M. A. S.
    Blood (2005)

    Fulltext@MSK | Save
  • Inactivation of the PRDM1/BLIMP1 gene in non-GC-type diffuse large B-cell lymphoma
    Meeting Abstract

    Pasqualucci, L.; Compagno, M.; Houldsworth, J.; Monti, S.; Grunn, A.; Shipp, M. A.; Dalla-Favera, R.
    Blood (2005)

    Fulltext@MSK | Save
  • Antigen-specific T lymphocyte function following unrelated cord blood transplantation (UCBT)
    Meeting Abstract

    Parkman, R.; Cohen, G.; Carter, S. L.; Weinberg, K. I.; Masinsin, B.; Guinan, E. C.; Kurtzberg, J.; Wagner, J. E.; Kernan, N. A.
    Blood (2005)

    Fulltext@MSK | Save